Earnings Feed
Start Free
Home/Filings/4/0001567619-22-019198
4//SEC Filing

Silva Francisco 4

Accession 0001567619-22-019198

CIK 0001505497other
View on SEC.govCompany Profile

Filed

Nov 3, 8:00 PM ET

Accepted

Nov 4, 4:27 PM ET

Size

24.8 KB

Accession

0001567619-22-019198

Insider Transaction Report

Form 4
Period: 2022-11-03
BioRestorative Therapies, Inc.BRTX
Silva Francisco
VP of Research and Development
Transactions
  • Disposition to Issuer

    Stock Option

    2022-11-03−42,059→ 0 total
    Exercise: $13.50Exp: 2031-11-04→ Common Stock (42,059 underlying)
  • Disposition to Issuer

    Stock Option

    2022-11-03−293,479→ 0 total
    Exercise: $13.50Exp: 2031-03-18→ Common Stock (293,479 underlying)
  • Award

    Stock Option

    2022-11-03+293,479→ 293,479 total
    Exercise: $5.08Exp: 2031-03-18→ Common Stock (293,479 underlying)
  • Award

    Stock Option

    2022-11-03+42,059→ 42,059 total
    Exercise: $5.08Exp: 2031-11-04→ Common Stock (42,059 underlying)
Holdings

  • Common Stock

    (indirect: By IRA)
    12,136

  • Stock Option

    Exercise: $3000.00Exp: 2022-12-07→ Common Stock (1 underlying)
    1

  • Stock Option

    Exercise: $3000.00Exp: 2024-02-18→ Common Stock (3 underlying)
    3

  • Stock Option

    Exercise: $3000.00From: 2014-03-12Exp: 2024-03-11→ Common Stock (1 underlying)
    1

  • Stock Option

    Exercise: $3000.00Exp: 2024-10-23→ Common Stock (9 underlying)
    9

  • Stock Option

    Exercise: $3000.00Exp: 2026-06-10→ Common Stock (15 underlying)
    15

  • Stock Option

    Exercise: $3000.00Exp: 2028-10-29→ Common Stock (25 underlying)
    25

  • Common Stock

    165,103

  • Stock Option

    Exercise: $3000.00Exp: 2023-10-04→ Common Stock (1 underlying)
    1

  • Stock Option

    Exercise: $3000.00Exp: 2025-09-04→ Common Stock (6 underlying)
    6

  • Stock Option

    Exercise: $3000.00Exp: 2027-07-12→ Common Stock (20 underlying)
    20
Footnotes (5)
  • [F1]Includes 103,008 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on November 18, 2022 and January 18, 2023, 1,037 shares on December 18, 2022 and February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
  • [F2]The option is currently exercisable.
  • [F3]The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  • [F4]The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.
  • [F5]The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

→
Entity typeother

Related Parties

1
  • filerCIK 0001527241

Filing Metadata

Form type
4
Filed
Nov 3, 8:00 PM ET
Accepted
Nov 4, 4:27 PM ET
Size
24.8 KB
View on SEC.gov